Internal Medicine, Pulmonary Disease · Cincinnati, OH
NPI
1164503355
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
200 Eden Ave
Cincinnati, OH, 45219
Phone (513) 475-8523
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
707 services
Medicare patients, 2024
205
Average age 70
Drug cost, 2024
$33.6M
5,746 prescriptions
Company payments, 2025
$90K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jean M Elwing was code 99215 (office e&m - established), 233 times for 151 patients. In total Jean M Elwing billed 707 services in 20 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 233 | 151 | $103.72 | $24K |
| 94618 Pulmonary Function Testing | Facility | 182 | 134 | $15.31 | $2,787 |
| 99233 Hospital E&M - Subsequent | Facility | 58 | 16 | $87.84 | $5,095 |
| 94729 Pulmonary Function Testing | Facility | 46 | 43 | $6.39 | $294 |
| 94726 Pulmonary Function Testing | Facility | 45 | 42 | $8.55 | $385 |
| 99205 Office E&M - New | Facility | 32 | 32 | $137.24 | $4,392 |
| 94010 Pulmonary Function Testing | Facility | 31 | 29 | $6.11 | $190 |
| 99214 Office E&M - Established | Facility | 30 | 28 | $71.06 | $2,132 |
| 94060 Pulmonary Function Testing | Facility | 16 | 15 | $7.19 | $115 |
By year: 2022 $45K for 664 services; 2023 $48K for 697 services; 2024 $43K for 707 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jean M Elwing prescribed most often to Medicare patients was Opsumit (Macitentan), with 677 prescriptions and refills. In total Jean M Elwing wrote 5,746 Medicare prescriptions that cost $33.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opsumit Macitentan | 677 | 679 | 82 | $8.6M |
| Uptravi Selexipag | 565 | 618 | 65 | $13.6M |
| Tadalafil Generic | 466 | 693 | 90 | $552K |
| Sildenafil Citrate Generic | 323 | 712 | 87 | $104K |
| Famotidine Generic | 323 | 908 | 110 | $4,130 |
| Ambrisentan Generic | 261 | 289 | 30 | $841K |
| Spironolactone Generic | 241 | 654 | 77 | $4,111 |
| Omeprazole Generic | 233 | 538 | 65 | $2,989 |
| Torsemide Generic | 224 | 520 | 61 | $3,982 |
| Adempas Riociguat | 179 | 179 | 21 | $2.4M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 174 | 209 | 58 | $5,353 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 157 | 240 | 39 | $154K |
| Furosemide Generic | 156 | 315 | 47 | $487 |
| Montelukast Sodium Generic | 139 | 353 | 43 | $1,143 |
| Winrevair Sotatercept-Csrk | 128 | 128 | 19 | $2.2M |
Brand drugs: 2,433 claims; generic drugs: 3,286 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jean M Elwing $90K ($90K in general payments such as food, travel and fees) from 10 companies. The largest payer was Merck Sharp & Dohme LLC with $30K.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 43 | $30K |
| Actelion Pharmaceuticals US, Inc. JNJ | 16 | $28K |
| United Therapeutics Corporation UTHR | 35 | $27K |
| Insmed, Inc. INSM | 2 | $4,808 |
| Liquidia Technologies, Inc. | 1 | $140 |
| Chiesi USA, Inc. | 1 | $110 |
| GlaxoSmithKline, LLC. GSK | 3 | $53.69 |
| Sandoz Inc. SDZ.SW | 1 | $22.47 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $16.3 |
| Pfizer Inc. PFE | 1 | $16.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.